Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Primary Purpose
Stage 0 Skin Melanoma, Stage I Skin Melanoma, Stage IA Skin Melanoma
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Internet-Based Intervention
Questionnaire Administration
Survey Administration
Sponsored by
About this trial
This is an interventional supportive care trial for Stage 0 Skin Melanoma
Eligibility Criteria
Inclusion Criteria:
- Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase I: From 3-36 months post-surgical treatment
- Phase I: Access to the internet
- Phase I: Able to speak and read English
- Phase I: Able to provide informed consent
- Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
- Phase II: From 3-24 months post-surgical treatment
- Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at least once during the past 2 months)
- Phase II: Not adherent to sun protection recommendations (i.e., mean score < 4 [which corresponds to "often"] on a 5-point scale [from 1 = "never" to 5 = "always"] that assesses the frequency of engaging in four sun protection behaviors)
- Phase II: Access to a computer connected to the internet
- Phase II: Able to speak and read English
- Phase II: Able to provide informed consent
Sites / Locations
- Rutgers Cancer Institute of New Jersey
- University of Virginia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Arm I (ITW)
Arm II (usual care)
Arm Description
Patients access ITW and complete each module over 30-40 minutes. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Patients receive usual care and are then offered ITW. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Outcomes
Primary Outcome Measures
Sun Protection Behavior Index
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Number of Participants That Performed a Thorough Skin Self-examination (SSE) in the Past 2 Months
Defined as thoroughly examining each area of the body during the most recent skin self-check in the last 2 months.
Secondary Outcome Measures
Performance of Thorough Skin-self-examination (SSE) in the Past 4 Months
Defined as thoroughly examining each area of the body during the most recent skin self-check in the past 4 months
Performance of Thorough Skin-self-examination (SSE) in the Past 6 Months
Defined as thoroughly examining each area of the body during the most recent skin self-check in the past 6 months
Number of SSEs Performed
Total number of SSEs performed (regardless of their thoroughness)
Number of Body Areas Examined
Total number of body areas examined during the most recent SSE in the last 2 months
Use of Tools to Facilitate SSE
Use of a mirror, having someone else help, or using a body mole map during the most recent SSE
Frequency of Engaging in Each Individual Sun Protection Behavior From the Sun Protection Behavior Index
Frequency (from 1 = never to 5 = always) of wearing sunscreen with an SPF ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade
Number of Sunburns
Total number of sunburns received
Wearing Long Pants
Frequency (from 1 = never to 5 = always) of wearing long pants
Wearing Sunglasses
Frequency (from 1 = never to 5 = always) of wearing sunglasses
Sunbathing
Frequency (from 1 = never to 5 = always) of spending time in the sun in order to get a tan
Sun Protection Behavior Index
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Sun Protection Behavior Index
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Sun Protection Behavior Index
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Full Information
NCT ID
NCT03028948
First Posted
January 19, 2017
Last Updated
February 6, 2023
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI), University of Virginia
1. Study Identification
Unique Protocol Identification Number
NCT03028948
Brief Title
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
Official Title
Internet Intervention for Sun Protection and Skin Self-check Behaviors
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
March 13, 2017 (Actual)
Primary Completion Date
July 12, 2019 (Actual)
Study Completion Date
July 12, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI), University of Virginia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Detailed Description
PRIMARY OBJECTIVES:
I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin self-examination (SSE) and sun protection behaviors among individuals diagnosed with melanoma.
SECONDARY OBJECTIVES:
I. To examine mediators of the impact of the intervention. The effects of the intervention on SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors, perceived barriers to SSE and sun protection behaviors, and perceived controllability of melanoma.
TERTIARY OBJECTIVES:
I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects are moderated by the following factors: time since diagnosis, disease stage, age, sex, income, education, Internet experience, distress about melanoma, worry about recurrence, and evaluation and usage of the ITW.
OUTLINE:
Phase I: Patients review draft website content materials in a semi-structured format and provide feedback via open- and closed-ended questions for the development, testing, and finalization of ITW.
Phase II: Patients are randomized into 1 of 2 arms.
ARM I: Patients access ITW and complete each module over 30-40 minutes.
ARM II: Patients receive usual care and are then offered ITW.
All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stage 0 Skin Melanoma, Stage I Skin Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma, Stage II Skin Melanoma, Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma, Stage III Skin Melanoma, Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
485 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Arm I (ITW)
Arm Type
Experimental
Arm Description
Patients access ITW and complete each module over 30-40 minutes. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Arm Title
Arm II (usual care)
Arm Type
Active Comparator
Arm Description
Patients receive usual care and are then offered ITW. All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.
Intervention Type
Other
Intervention Name(s)
Internet-Based Intervention
Intervention Description
Access ITW
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Ancillary studies
Intervention Type
Other
Intervention Name(s)
Survey Administration
Intervention Description
Ancillary studies
Primary Outcome Measure Information:
Title
Sun Protection Behavior Index
Description
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Time Frame
At 24 weeks
Title
Number of Participants That Performed a Thorough Skin Self-examination (SSE) in the Past 2 Months
Description
Defined as thoroughly examining each area of the body during the most recent skin self-check in the last 2 months.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Performance of Thorough Skin-self-examination (SSE) in the Past 4 Months
Description
Defined as thoroughly examining each area of the body during the most recent skin self-check in the past 4 months
Time Frame
At 24 weeks
Title
Performance of Thorough Skin-self-examination (SSE) in the Past 6 Months
Description
Defined as thoroughly examining each area of the body during the most recent skin self-check in the past 6 months
Time Frame
48 weeks
Title
Number of SSEs Performed
Description
Total number of SSEs performed (regardless of their thoroughness)
Time Frame
At 8, 24 and 48 weeks
Title
Number of Body Areas Examined
Description
Total number of body areas examined during the most recent SSE in the last 2 months
Time Frame
At 8, 24 and 48 weeks
Title
Use of Tools to Facilitate SSE
Description
Use of a mirror, having someone else help, or using a body mole map during the most recent SSE
Time Frame
At 8, 24 and 48 weeks
Title
Frequency of Engaging in Each Individual Sun Protection Behavior From the Sun Protection Behavior Index
Description
Frequency (from 1 = never to 5 = always) of wearing sunscreen with an SPF ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade
Time Frame
At 8, 24 and 48 weeks
Title
Number of Sunburns
Description
Total number of sunburns received
Time Frame
At 8, 24 and 48 weeks
Title
Wearing Long Pants
Description
Frequency (from 1 = never to 5 = always) of wearing long pants
Time Frame
At 8, 24 and 48 weeks
Title
Wearing Sunglasses
Description
Frequency (from 1 = never to 5 = always) of wearing sunglasses
Time Frame
At 8, 24 and 48 weeks
Title
Sunbathing
Description
Frequency (from 1 = never to 5 = always) of spending time in the sun in order to get a tan
Time Frame
At 8, 24 and 48 weeks
Title
Sun Protection Behavior Index
Description
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Time Frame
Baseline
Title
Sun Protection Behavior Index
Description
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Time Frame
At 8 weeks
Title
Sun Protection Behavior Index
Description
Participants rated how often they engaged in four behaviors when outside on a sunny day: wearing sun screen with an Sun Protection Factor ≥ 30, wearing a long-sleeved shirt, wearing a wide-brimmed hat, and staying in the shade. Items were rated on a five-point Likert scale (1=never, 2= rarely, 3= sometimes, 4= often, 5=always). In this case, higher values are associated with more protection behaviors. Subscales were averaged to compute the total index score.
Time Frame
At 48 weeks
Other Pre-specified Outcome Measures:
Title
Distress About Melanoma
Description
Level of distress (from 1 = not at all distressed to 10 = extremely distressed)
Time Frame
At 8, 24 and 48 weeks
Title
Worry About Melanoma Recurrence
Description
Mean rating of four questions regarding worry about melanoma recurrence
Time Frame
At 8, 24 and 48 weeks
Title
Perceived Risk of Melanoma Recurrence
Description
Mean rating of four questions regarding perceived risk of melanoma recurrence
Time Frame
At 8, 24 and 48 weeks
Title
Biopsies Conducted
Description
Number of biopsies conducted
Time Frame
At 48 weeks
Title
Indoor Tanning
Description
Number of times indoor tanned in the past year
Time Frame
At 48 weeks
Title
Diagnosis of New or Recurrent Skin Cancers
Description
Whether a new or recurrent skin cancer was diagnosed
Time Frame
At 48 weeks
Title
Indicators of Study Feasibility
Description
Ineligibility rate and reasons, recruitment rate and reasons for refusal, differences in sociodemographic factors between study decliners and those recruited, dropout rate and reasons.
Time Frame
At 48 weeks
Title
Visits to Healthcare Provider Related to Skin Surveillance
Description
Receipt of a physician skin examination and the reason for the visit
Time Frame
At 8, 24 and 48 weeks
Title
Impact and Effectiveness of the Interactive Tailored Website
Description
Perceived Internet Impact and Effectiveness Questionnaire was used. This 20-item survey was used to measure the degree to which MSS helped the participant learn how to be prepared to conduct SSE and engage in sun protection behaviors as well as feel in control of his/her health and feel less worried about melanoma. A Likert scale was used for each question (1=not at all, 2=slightly, 3=somewhat, 4=mostly, 5=very). The scores from each question were averaged to compute the total scale score for each participant. The total scores for each participant were also averaged to find the overall average across MSS participants. Higher values represent greater effectiveness of the program.
Time Frame
At 8 weeks
Title
Usage of the Interactive Tailored Website
Description
Number of visits to the website, the number of monthly skin self-checks completed, the number of updates to the sun-safe action plan, and starting/completing the remaining sections of the website (Introduction; Getting Ready to Do a Skin Self-Check; Practice Sun-Safe Behaviors).
Time Frame
At 8, 24 and 48 weeks
Title
Evaluation and Utility of the Interactive Tailored Website
Description
Internet Evaluation and Perceived Utility Questionnaire and the Internet Adherence Questionnaire was used. This 15-item survey assessed the program characteristics, including usefulness, convenience, ease of use, worry about privacy, ease of navigation, and satisfaction with the program. A Likert scale was used for each question (1=not at all, 2=slightly, 3=somewhat, 4=mostly, 5=very). The scores from each question were averaged to compute the total scale score for each participant. The total scores for each participant were also averaged to find the overall average across MSS participants. Higher values represent higher scores in terms of utility and evaluation of the program.
Time Frame
At 8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
Phase I: From 3-36 months post-surgical treatment
Phase I: Access to the internet
Phase I: Able to speak and read English
Phase I: Able to provide informed consent
Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
Phase II: From 3-24 months post-surgical treatment
Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at least once during the past 2 months)
Phase II: Not adherent to sun protection recommendations (i.e., mean score < 4 [which corresponds to "often"] on a 5-point scale [from 1 = "never" to 5 = "always"] that assesses the frequency of engaging in four sun protection behaviors)
Phase II: Access to a computer connected to the internet
Phase II: Able to speak and read English
Phase II: Able to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elliot Coups
Organizational Affiliation
Rutgers Cancer Institute of New Jersey
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rutgers Cancer Institute of New Jersey
City
New Brunswick
State/Province
New Jersey
ZIP/Postal Code
08903
Country
United States
Facility Name
University of Virginia
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22904
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
31255801
Citation
Coups EJ, Manne SL, Ohman Strickland P, Hilgart M, Goydos JS, Heckman CJ, Chamorro P, Rao BK, Davis M, Smith FO, Thorndike FP, Ritterband LM. Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics. Contemp Clin Trials. 2019 Aug;83:117-127. doi: 10.1016/j.cct.2019.06.014. Epub 2019 Jun 27.
Results Reference
derived
Learn more about this trial
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
We'll reach out to this number within 24 hrs